Investor Centre

Investor Fact Sheet

Open 0.10
High 0.10
Low 0.10
Volume 294,454
( 0.0%
As at 3:24PM 07/12/2021

Investor Fact Sheet

Acrux (ASXOpens in new window : ACR) is a pharmaceutical company dedicated to developing and commercialising topical pharmaceuticals. Incorporated in 1998 and using in house facilities and capabilities, Acrux has successfully developed and commercialised through licensees a number of topically applied pharmaceutical products in the US and Europe. Acrux is developing a range of generic products for the US market by leveraging its on-site laboratories, GMP manufacturing suite, clinical and commercial experience to bring affordable products to market. Acrux encourages collaboration and is well positioned to discuss partnering and product development.

Learn more about Acrux Learn more about our history

Security Information

Share Price 

Acrux is listed on the Australian Securities Exchange (ASX code: ACR).

View Share Price Information View Announcements & Reports

Board of Directors

Ross Dobinson — Non-Executive Chairman
Geoff Brooke — Non-Executive Director
Tim Oldham — Non-Executive Director
Don Brumley — Non-Executive Director

Michael Kotsanis — CEO & Managing Director

Tim Oldham — Chair, Human Capital Committee

Don Brumley — Chair, Audit and Risk Committee

Joanna Johnson — CFO & Company Secretary


103-113 Stanley Street West Melbourne VIC 3003 Australia

Share Registry

Link Market Services
Tower 4, 727 Collins Street,
Locked Bag A14, Sydney South, NSW 1235

Toll-free: 1300 554 474 (Australia only)
International: +61 1300 554 474
Facsimile: (02) 9287 0303
Facsimile: (02) 9287 0309 (for proxy voting)

Web: in new window


Pitcher Partners
Level 13, 664 Collins Street,
Docklands VIC 3008

Telephone: +61 3 8610 5000
Facsimile: +61 3 8610 5999